Abstract
Rabies is routinely diagnosed based on the clinical description and history of exposure in a rabies-endemic country. A negative diagnostic test for rabies virus or a related lyssavirus does not exclude the clinical diagnosis. Diagnostic tests are never optimal and are entirely dependent on the nature and quality of the sample supplied. Often, only a sample from a single time point is investigated reducing the overall sensitivity of any diagnosis. With the advent of molecular biology, tests have been developed that are rapid, robust, and sensitive in support of the rapid detection and strain identification of rabies virus from clinical specimens. These molecular tests complement conventional tests in rabies diagnosis, particularly for human cases, for which an early laboratory diagnosis is critical and may decrease the number of unnecessary contacts with the patient, reduce the requirement for invasive and costly interventions, and enable the appropriate medical treatment regimen to be administered for the patient. The barrier to success is in transferring the technology for the latest techniques in rabies diagnosis to rabies-endemic countries. These barriers are not insurmountable and in liaison with international organisations, especially OIE, FAO, and WHO, these diagnostic tests will be validated for rabies diagnosis and surveillance, and implemented in modern and well-equipped diagnostic laboratories throughout the world.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Jackson, A.C. and Wunner, W.H. (2007) Rabies, 2nd Edn. Elsevier Inc, London, pp. 635–643.
Johnson, N., Wade-Lipscomb, D., Stott, R., Rao, G.G., Mansfield, K., Smith, J., McElhinney, L.M., and Fooks, A.R. (2002) Investigation of a human case of rabies in the United Kingdom. J Clin Virol 25, 351–356.
Noah, D.L., Drenzek, C.L., Smith, J.S., Krebs, J.W., Orciari, L., Shaddock, J., Sanderlin, D., Whitfield, S., Fekadu, M., Olson, J.G., Rupprecht, C.E., and Childs, J.E. (1998) Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 128, 922–930.
Smith, J., McElhinney, L.M., Parsons, G., Brink, N., Doherty, T., Agranoff, D., Miranda, M.E., and Fooks, A.R. (2003) Case report: rapid antemortem diagnosis of a human case of rabies imported into the UK from the Philippines. J Med Virol 69, 150–155.
Nathwani, D., McIntyre, P.G., White, K., Shearer, A.J., Reynolds, N., Walker, D., Orange, G.V., and Fooks, A.R. (2003) Fatal human rabies caused by European bat Lyssavirus type-2a infection in Scotland. Clin Infect Dis 37, 598–601.
Bingham, J. and van der Merwe, M. (2002) Distribution of rabies antigen in infected brain material: determining the reliablility of different regions of the brain for the rabies fluorescent antibody test. J Virol Methods 101, 85–94.
Meslin, F.-X., Kaplin, M.M., and Koprowski, H., (1996) Laboratory Techniques in Rabies, 4th Edn. World Health Organisation, Geneva, pp. 88–95.
Wright, E., Temperton, N.J., Marston, D., McElhinney, L.M., Fooks, A.R., and Weiss, R.A. (2008) Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison. J Gen Virol 89, 1–10.
Brookes, S.M., Healy, D.M., and Fooks, A.R. (2006) Ability of rabies vaccine strains to elicit cross-neutralising antibodies. Dev Biol (Basel) 125, 185–193.
Dacheux, L., Reynes, J.-M., Buchy, P., Sivuth, O., Diop, B.M., Rousset, D., Rathat, C., Jolly, N., Dufourcq, J.-B., Nareth, C., Diop, C., Lehle, C., Rajerison, R., Sadorge, C., and Bourhy, H. (2008) A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 47, 1410–1417.
Cliquet, F., Aubert, M., and Sagne L. (1998) Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods 212, 79–87.
Picard-Meyer, E. and Cliquet, F. (2007) Use of filter paper (FTA®) technology for sampling, recovery and molecular characterisation of rabies viruses. J Virol Methods 140, 174–182.
Black, E.M., Lowings, J.P., Smith, J., Heaton, P.R., and McElhinney, L.M. (2003) Corrigendum: a rapid RT-PCR method to differentiate six established genotypes of rabies and rabiesrelated viruses using TaqMan (TM) technology. J Virol Methods 111, 163.
Heaton, P.R., Johnstone, P., McElhinney, L.M., Cowley, R., O’Sullivan, E., and Whitby, J. (1997) Hemi-nested PCR assay for detection of six genotypes of rabies and rabies-related viruses. J Clin Microbiol 35(11), 2762–2766.
Wakeley, P.R., Johnson, N., McElhinney, L.M., Marston, D., Sawyer, J., and Fooks, A.R. (2005) Development of a real-time, TaqMan reverse transcription-PCR assay for detection and differentiation of lyssavirus genotypes 1, 5 and 6. J Clin Microbiol 43, 2786–2792.
King, A.A. (1993) Monoclonal antibody studies on rabies-related viruses. Onderstepoort J Vet Res 60, 283–287.
Acknowledgements
GH and ARF are funded by the UK Department for Environment, Food, and Rural Affairs (Defra grant SEV3500).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Harkess, G., Fooks, A.R. (2010). Lyssaviruses: Special Emphasis on Rabies Virus and Other Members of the Lyssavirus Genus. In: Stephenson, J., Warnes, A. (eds) Diagnostic Virology Protocols. Methods in Molecular Biology, vol 665. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-817-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-60761-817-1_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-816-4
Online ISBN: 978-1-60761-817-1
eBook Packages: Springer Protocols